Brainsway Ltd. (BWAY) intrinsic value & 10-year financials

Brainsway Ltd. (BWAY) has a Graham intrinsic value of $1.66 per share. Over the last 9 fiscal years revenue grew 20.5% a year to $41.0M, with an average return on invested capital of -223.7%.

Graham intrinsic value
$1.66
Revenue (FY2024)
$41.0M
Revenue growth (9-yr CAGR)
20.5%
ROIC (10-yr avg)
-223.7%
Free cash flow (FY2024)
—

BWAY 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2024 $41.0M $2.9M $0.05 — 3.4% 2.3%
FY2023 $31.8M -$4.2M -$0.13 — -15.6% -11.4%
FY2022 $27.2M -$13.3M -$0.40 — -46.7% -24.7%
FY2021 $29.7M -$6.5M -$0.21 -$1.4M -16.9% -13.0%
FY2020 $22.1M -$5.4M — -$3.9M -21.9% -22.0%
FY2019 $23.1M -$10.3M — -$10.6M -36.7% -1037.5%
FY2018 $16.4M -$6.5M — -$5.7M -31.2% -625.9%
FY2017 $11.1M -$7.1M — -$4.5M -59.3% -57.5%
FY2016 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Brainsway Ltd. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Brainsway Ltd. has historically struggled to out-earn its cost of capital, averaging just -8.3% ROIC.

Brainsway Ltd. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Brainsway Ltd. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.66 per share.

BWAY stock: frequently asked questions

What is the intrinsic value of Brainsway Ltd. (BWAY) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, BWAY's intrinsic value is about $1.66 per share.

What is BWAY's return on invested capital?

Average ROIC over the last 9 fiscal years was -223.7%, and average return on equity was -33.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this BWAY data come from?

From Brainsway Ltd.'s annual 10-K filings on SEC EDGAR, most recently filed Apr 20, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks